(Sigma) for 20 min, followed by permeabilization with 0.3% Triton-X 100 for 5
min at room temperature. Next, the cells were incubated with 10% sheep serum for
30 min at 37°C for protein blocking. To characterize the differentiated RPE-like
cells, the following primary antibodies were used: RPE65 (MAB5428, 1:100; Merck,
Darmstadt, Germany), CRALBP (ab1501, 1:100; Abcam, Cambridge, UK), and zonula
occludens-1 (ZO-1, LS-B9774, 1:100; LifeSpan BioSciences, Seattle, WA, USA). The
incubation with primary antibodies was conducted at 4°C overnight, followed by
incubation with FITC-conjugated secondary antibodies at room temperature for 1
h. The ARPE19 cells served as a positive control.